These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A model for optimization of biomarker testing frequency to minimize disease and cost: example of beryllium sensitization testing. Judd NL, Griffith WC, Takaro T, Faustman EM. Risk Anal; 2003 Dec; 23(6):1211-20. PubMed ID: 14641896 [Abstract] [Full Text] [Related]
24. Comparison of in vivo and in vitro measures of beryllium sensitization. Bobka CA, Stewart LA, Engelken GJ, Golitz LE, Newman LS. J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212 [Abstract] [Full Text] [Related]
25. Rocky Flats Beryllium Health Surveillance. Stange AW, Furman FJ, Hilmas DE. Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045 [Abstract] [Full Text] [Related]
26. [Beryllium--underestimated occupational health hazard in Poland]. Dudek W, Walusiak J, Wittczak T. Med Pr; 2001 Oct; 52(6):471-8. PubMed ID: 11928678 [Abstract] [Full Text] [Related]
27. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C. Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174 [Abstract] [Full Text] [Related]
28. Statistical methods for the blood beryllium lymphocyte proliferation test. Frome EL, Smith MH, Littlefield LG, Neubert RL, Colyer SP. Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):957-68. PubMed ID: 8933042 [Abstract] [Full Text] [Related]
29. Immunogenetic factors in beryllium sensitization and chronic beryllium disease. Weston A, Snyder J, McCanlies EC, Schuler CR, Andrew ME, Kreiss K, Demchuk E. Mutat Res; 2005 Dec 30; 592(1-2):68-78. PubMed ID: 16054169 [Abstract] [Full Text] [Related]
30. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment. Borak J, Woolf SH, Fields CA. J Occup Environ Med; 2006 Sep 30; 48(9):937-47. PubMed ID: 16966961 [Abstract] [Full Text] [Related]
31. Hygienic and toxicological aspects of occupational and environmental exposure to beryllium. Bencko V, Vasil'eva EV. J Hyg Epidemiol Microbiol Immunol; 1983 Sep 30; 27(4):403-17. PubMed ID: 6663073 [Abstract] [Full Text] [Related]
33. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. J Occup Environ Med; 2001 Mar 30; 43(3):231-7. PubMed ID: 11285871 [Abstract] [Full Text] [Related]
39. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Cummings KJ, Deubner DC, Day GA, Henneberger PK, Kitt MM, Kent MS, Kreiss K, Schuler CR. Occup Environ Med; 2007 Feb 30; 64(2):134-40. PubMed ID: 17043076 [Abstract] [Full Text] [Related]
40. [Characteristics of the functional state of the lymphocytes in berylliosis studied by the blast transformation method]. Shpakova AP, Ermakova NG. Sov Med; 1979 Apr 30; (4):20-4. PubMed ID: 312533 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]